Thomas K Equels - CEO & President at AIM ImmunoTech Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & President
Issuer Symbol
AIM on NYSE
All Insider Reports
All Insider Reports

Thomas K Equels - trading volume in the past year for AIM ImmunoTech Inc.

Holdings reported by Thomas K Equels for AIM ImmunoTech Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 38,922 $30,748 $0.7900 06 Mar 2026 Direct
Class G Warrants 50,000 06 Mar 2026 Direct Common Stock
Series G Convertible Preferred Stock 25 06 Mar 2026 Direct Series G Convertible Preferred Stock

Transactions reported by Thomas K Equels for AIM ImmunoTech Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.